What's happening

1X Technologies launched mass production at its new 58,000 square foot vertically integrated factory in Hayward, California on April 30, 2026, marking a rapid transition from announcement to full-scale manufacturing operations. The facility targets production of 10,000 NEO humanoid robots in its first year, with plans to scale capacity to over 100,000 units annually by the end of 2027.

The OpenAI-backed company demonstrated strong early market demand, with its entire first-year production capacity selling out within five days of preorder launch on October 28, 2025. NEO robots are priced at $20,000 for early access with priority 2026 delivery, or available through a $499 monthly subscription model, with consumer shipments planned to begin before the end of 2026.

Why it matters for markets

The factory opening represents a significant scaling milestone in the humanoid robotics market, with 1X's production targets translating to potential annual revenue of $200 million at current pricing for 10,000 units, scaling to over $2 billion annually if the company achieves its 100,000 unit target by 2027. The rapid sellout of initial production capacity demonstrates commercial viability for home-use humanoid robots at the $20,000 price point.

1X's funding trajectory reflects growing investor confidence in physical AI commercialization, having raised $23.5 million in Series A2 funding in March 2023 led by OpenAI Startup Fund, followed by $100 million in Series B funding in January 2024 from EQT Ventures with participation from Samsung NEXT, OpenAI, and Tiger Global. The company was seeking up to $1 billion in new funding at a target valuation of at least $10 billion as of September 2025.

The establishment of large-scale US manufacturing capacity for humanoid robots intensifies competition in the physical AI sector, particularly as companies race to achieve commercial production volumes that could drive down unit costs and expand addressable markets beyond early adopters.

Sectors and assets to watch

The humanoid robotics manufacturing scale-up creates demand for specialized components and processing power, particularly benefiting semiconductor companies that provide AI inference chips and sensors required for autonomous robot operation. NVIDIA, trading at $198.45 with a $4.82 trillion market cap, supplies GPU technology that enables the AI processing capabilities essential for humanoid robot functionality.

Manufacturing automation and precision robotics companies stand to benefit from the production scaling requirements, as vertically integrated factories like 1X's facility require sophisticated assembly and testing equipment. The consumer robotics supply chain, including battery technology, actuators, and sensor manufacturers, faces increased demand as production targets reach 100,000+ units annually.

What to watch next

Monitor 1X's ability to meet its consumer shipment timeline before end of 2026 and achieve the aggressive scaling from 10,000 to 100,000+ units by end of 2027. Track completion of the company's reported $1 billion funding round at the $10 billion target valuation, which would signal continued investor confidence in humanoid robotics commercialization and provide capital for the planned production scaling.